Abdulla W, Netter U
Department of Anaesthesiology and Intensive Care Medicine, Klinikum Bernburg.
Acta Anaesthesiol Belg. 2005;56(2):179-82.
The use of thrombolytics for the treatment of massive pulmonary embolism with cardiopulmonary resuscitation is being controversially discussed. This is one of the first reports on the successful use of tenecteplase in a 59-year-old man who survived a massive pulmonary embolism after tracheostomy followed by a 30-minute cardiopulmonary resuscitation without cerebral damage. In such a dramatic clinical event, the immediate and simple use of this modern thrombolytic appears to be a justifiable last-resort treatment option until controlled studies in sufficiently sized patient populations will have proven or refuted its efficacy and safety.
关于使用溶栓剂治疗伴有心肺复苏的大面积肺栓塞一直存在争议。本文是关于替奈普酶成功用于一名59岁男性患者的首批报道之一,该患者在气管切开术后发生大面积肺栓塞,经30分钟心肺复苏后存活,且无脑损伤。在如此危急的临床事件中,在足够规模的患者群体中进行对照研究证实或反驳其有效性和安全性之前,立即且简单地使用这种现代溶栓剂似乎是一种合理的最后手段治疗选择。